Annual Report 2011 - Goodbaby International Holdings Limited
Annual Report 2011 - Goodbaby International Holdings Limited
Annual Report 2011 - Goodbaby International Holdings Limited
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
pursuant to which each of the Covenantors has<br />
separately undertaken to the Company that she/<br />
he/it shall not and will procure that her/his/its<br />
associates shall not, among other matters,<br />
directly or indirectly engage, participate, or hold<br />
any right or interest in, or otherwise be involved<br />
in any business which is or may be in competition<br />
with the businesses of the Company and its<br />
subsidiaries (in existence from time to time).<br />
Details of the Deed of Non-Competition were<br />
disclosed in the Company’s prospectus for global<br />
offering dated 11 November 2010 (the<br />
“Prospectus”) under the section headed<br />
“Relationship with Our Controlling Shareholders”.<br />
Each of the Covenantors has provided an annual<br />
declaration on his/her/its compliance with the<br />
undertakings contained in the Deed of Non<br />
Competition undertaken by them. The<br />
independent non-executive Directors have<br />
reviewed and were satisfied that each of the<br />
Covenantors has complied with the Deed of Non-<br />
Competition for the year ended 31 December<br />
<strong>2011</strong>.<br />
SHARE OPTION SCHEME<br />
On 5 November 2010, the Company adopted a<br />
share option scheme (“Share Option Scheme”)<br />
whereby the Board of Directors can grant options<br />
for the subscription of the Company’s shares to<br />
any full-time or part-time employees, executives<br />
or officers of the Company or any of its<br />
subsidiaries, any directors (including nonexecutive<br />
and independent non-executive<br />
directors) of the Company or any of its<br />
subsidiaries and advisers, consultants, suppliers,<br />
customers, agents and such other persons who in<br />
the sole opinion of the Board will contribute or<br />
have contributed to the Company or any of its<br />
subsidiaries as described in the Share Option<br />
Scheme as incentives or rewards for their<br />
contribution to the Group for the purpose of<br />
/ 53<br />
motivating the eligible participants to optimize<br />
their performance efficiency for the benefit of the<br />
Group; and attracting and retaining or otherwise<br />
maintaining on-going business relationship with<br />
the eligible participants whose contributions are<br />
or will be beneficial to the long-term growth of<br />
the Group.<br />
Since the Share Option Scheme was adopted, no<br />
options have been granted as at 31 December<br />
<strong>2011</strong>. Up to the date of this report, the Company<br />
has granted to certain eligible participants,<br />
subject to their acceptance, a total of 30,551,000<br />
options on 3 January 2012.<br />
As at 31 December <strong>2011</strong>, the total number of<br />
shares available for issue under the Share Option<br />
Scheme was 100,000,000 shares, which<br />
represented 10% of the shares in issue as at the<br />
date of this annual report.<br />
The options issued pursuant to the Share Option<br />
Scheme will expire no later than 10 years from the<br />
date of grant of the option.<br />
For any options granted to Directors, chief<br />
executives or substantial shareholders of the<br />
Company, or any of their respective associate,<br />
options to be granted to any of these persons<br />
shall be approved by the independent nonexecutive<br />
Directors (excluding any independent<br />
non-executive Director who is the proposed<br />
grantee of options). Where any option granted to<br />
a substantial shareholder or an independent nonexecutive<br />
Director, or any of their respective<br />
associates, would result in the shares issued or to<br />
be issued upon exercise of all options already<br />
granted and to be granted to such person in the<br />
12 month period, (i) representing in aggregate<br />
over 0.1% of the shares in issue on the date of<br />
such grant; and (ii) having an aggregate value,<br />
based on the closing price of the shares, in excess<br />
of HK$5 million, such grant of options shall be<br />
subject to prior approval by resolutions of the<br />
shareholders (voting by way of poll).